榴莲视频

Early interventions with hearing aids attenuated the risk

Changes in CAFS, ALSFRS-R scores comparable at 48 weeks

Insurance claims data show lower glucocorticoid usage at 1 year

Nipocalimab plus standard of care reduced IgG and was well tolerated

Differences between delandistrogene moxeparvovec and placebo emerge in secondary outcomes

Round-the-clock infusion delivers carbidopa and levodopa pro-drugs

Study may ease fears about potential neurodevelopmental effects of fetal COVID exposure

Phase III trial met primary endpoint at 6 months

Topline phase III data show inebilizumab met primary endpoint

News and commentary from the world of neurology and neuroscience

Nearly 6% of lecanemab may be discarded each year

Feeling lonely also linked with cognitive impairment that's not dementia, meta-analysis shows

10% of patients in trials leading to eli-cel's approval developed MDS or AML

Bladder, brain, and cervical cancer risks were higher in people with MS